Congenital Malignant Disorders

Avery's Diseases of the Newborn

Volumn , Issue , 2005, Pages 1437-1470

  Loh, Mignon L ^a,b   Matthay, Katherine K ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882555903     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-072169347-7.50097-4     Document Type: Chapter

References (221)

1. Ablin AR, Krailo MD, Ramsay NK, et al. Results of treatment of malignant germ cell tumors in 93 children: A report from the Children's Cancer Study Group. J Clin Oncol 1991, 9:1782-1792.
2. Anders D, Frick R, Kindermann G [Metastasizing neuroblastoma of the fetus with seeding in the placenta]. Geburtshilfe Frauenheilkd 1970, 30:969-975.
3. Anderson JF, Kent S, Machin GA Maternal malignant melanoma with placental metastasis: A case report with literature review. Pediatr Pathol 1989, 9:35-42.
4. Antunes NL, Khakoo Y, Matthay KK, et al. Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus. J Pediatr Hematol Oncol 2000, 22:315-320.
5. Arico M, Janka G, Fischer A, et al. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia 1996, 10:197-203.
6. Armstrong SA, Staunton JE, Silverman LB, et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002, 30:41-47.
7. Aviles A, Neri N Hematological malignancies and pregnancy: A final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2001, 2:173-177.
8. Baird PN, Pritchard J, Cowell JK Molecular genetic analysis of chromosome 11p in familial Wilms tumour. Br J Cancer 1994, 69:1072-1077.
9. Barak M, Cohen A, Herschkowitz S Total leukocyte and neutrophil count changes associated with antenatal betamethasone administration in premature infants. Acta Paediatr 1992, 81:760-763.
10. Belchis DA, Mowry J, Davis JH Infantile choriocarcinoma: Re-examination of a potentially curable entity. Cancer 1993, 72:2028-2032.
11. Bibbo M, Gill WB, Azizi F, et al. Follow-up study of male and female offspring of DES-exposed mothers. Obstet Gynecol 1977, 49:1-18.
12. Biegel JA, White PS, Marshall HN, et al. Constitutional 1p36 deletion in a child with neuroblastoma. Am J Hum Genet 1993, 52:176-182.
13. Blattner WA, Henson DE, Young RC, et al. Malignant mesenchymoma and birth defects: Prenatal exposure to phenytoin. Jama 1977, 238:334-335.
14. Bleyer AW Clinical pharmacology of intrathecal methotrexate. II. An improved dosage regimen derived from age-related pharmacokinetics. Cancer Treat Rep 1977, 61:1419-1425.
15. Bonnin JM, Rubinstein LJ, Palmer NF, et al. The association of embryonal tumors originating in the kidney and in the brain: A report of seven cases. Cancer 1984, 54:2137-2146.
16. Bourhis J, Dominici C, McDowell H, et al. N- myc genomic content and DNA ploidy in stage IVS neuroblastoma. J Clin Oncol 1991, 9:1371-1375.
17. Bove KE, McAdams AJ The nephroblastomatosis complex and its relationship to Wilms' tumor: A clinicopathologic treatise. Perspect Pediatr Pathol 1976, 3:185-223.
18. Bowman LC, Castleberry RP, Cantor A, et al. Genetic staging of unresectable or metastatic neuroblastoma in infants: A Pediatric Oncology Group study. J Natl Cancer Inst 1997, 89:373-380.
19. Bown N, Cotterill S, Lastowska M, et al. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med 1999, 340:1954-1961.
20. Breccia M, Cimino G, Alimena G, et al. AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation. Haematologica 2002, 87. ELT12.
21. Bresters D, Reus AC, Veerman AJ, et al. Congenital leukaemia: The Dutch experience and review of the literature. Br J Haematol 2002, 117:513-524.
22. Brissette MD, Duval-Arnould BJ, Gordon BG, et al. Acute megakaryoblastic leukemia following transient myeloproliferative disorder in a patient without Down syndrome. Am J Hematol 1994, 47:316-319.
23. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993, 11:1466-1477.
24. Brodeur GM, Seeger RC, Schwab M, et al. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984, 224:1121-1124.
25. Bruinsma F, Venn A, Lancaster P, et al. Incidence of cancer in children born after in-vitro fertilization. Hum Reprod 2000, 15:604-607. Also available at http://humrep.oupjournals.org/cgi/content/full/15/3/604 http://humrep.oupjournals.org/cgi/content/abstract/15/3/604.
26. Cairney AE, Andrews M, Greenberg M, et al. Wilms tumor in three patients with Bloom syndrome. J Pediatr 1987, 111:414-416.
27. Calhoun DA, Kirk JF, Christensen RD Incidence, significance, and kinetic mechanism responsible for leukemoid reactions in patients in the neonatal intensive care unit: A prospective evaluation. J Pediatr 1996, 129:403-409.
28. Caron H Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma. Med Pediatr Oncol 1995, 24:215-221.
29. Cavenee WK, Murphree AL, Shull MM, et al. Prediction of familial predisposition to retinoblastoma. N Engl J Med 1986, 314:1201-1207.
30. Chan HS, Cheng MY, Mancer K, et al. Congenital mesoblastic nephroma: A clinicoradiologic study of 17 cases representing the pathologic spectrum of the disease. J Pediatr 1987, 111:64-70.
31. Chen CS, Sorensen PH, Domer PH, et al. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood 1993, 81:2386-2393.
32. Chessells JM, Eden OB, Bailey CC, et al. Acute lymphoblastic leukaemia in infancy: Experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia. Leukemia 1994, 8:1275-1279.
33. Chessells JM, Harrison CJ, Kempski H, et al. Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: Report from the MRC Childhood Leukaemia working party. Leukemia 2002, 16:776-784.
34. Christiansen H, Lampert F Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma. Br J Cancer 1988, 57:121-126.
35. Coppes MJ, Clericuzio CL Molecular genetic analysis of the WT1 gene in patients suspected to have the Denys-Drash syndrome. Med Pediatr Oncol 1994, 23:390.
36. Cowell J, Pritchard J The molecular genetics of retinoblastoma and Wilms' tumor. Crit Rev Oncol Hematol 1987, 7:153-168.
37. Crist W, Pullen J, Boyett J, et al. Clinical and biologic features predict a poor prognosis in acute lymphoid leukemias in infants: A Pediatric Oncology Group Study. Blood 1986, 67:135-140.
38. Cunha GR, Taguchi O, Namikawa R, et al. Teratogenic effects of clomiphene, tamoxifen, and diethylstilbestrol on the developing human female genital tract. Hum Pathol 1987, 18:1132-1143.
39. D'Angio GJ, Breslow N, Beckwith JB, et al. Treatment of Wilms' tumor: Results of the Third National Wilms' Tumor Study. Cancer 1989, 64:349-360.
40. D'Angio GJ, Evans AE, Breslow N, et al. The treatment of Wilms' tumor: Results of the Second National Wilms' Tumor Study. Cancer 1981, 47:2302-2311.
41. D'Angio GJ, Evans AE, Koop CE Special pattern of widespread neuroblastoma with a favourable prognosis. Lancet 1971, 1:1046-1049.
42. De Bernardi B, Pianca C, Pistamiglio P, et al. Neuroblastoma with symptomatic spinal cord compression at diagnosis: Treatment and results with 76 cases. J Clin Oncol 2001, 19:183-190.
43. Dildy GA, Moise KJ, Carpenter RJ, et al. Maternal malignancy metastatic to the products of conception: A review. Obstet Gynecol Surv 1989, 44:535-540.
44. Donaldson SS, Smith LM Retinoblastoma: Biology, presentation, and current management. Oncology (Huntingt) 1989, 3:45-51. discussion 51-52.
45. Dordelmann M, Schrappe M, Reiter A, et al. Down's syndrome in childhood acute lymphoblastic leukemia: Clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Munster Group. Leukemia 1998, 12:645-651.
46. Ehrenbard LT, Chaganti RS Cancer in the fetal hydantoin syndrome. Lancet 1981, 2:97.
47. Eisinger F, Noizet A [Pregnancy and breast cancer: Decisions and mother's perspectives]. Bull Cancer 2002, 89:755-757.
48. Evans AE, D'Angio GJ, Randolph J A proposed staging for children with neuroblastoma. Children's Cancer Study Group A. Cancer 1971, 27:374-378.
49. Everson TC Spontaneous regression of cancer. Prog Clin Cancer 1967, 3:79-95.
50. Exelby PR, Filler RM, Grosfeld JL Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey 1974. J Pediatr Surg 1975, 10:329-337.
51. Fadilah SA, Ahmad-Zailani H, Soon-Keng C, et al. Successful treatment of chronic myeloid leukemia during pregnancy with hydroxyurea. Leukemia 2002, 16:1202-1203.
52. 131I in neuroblastoma diagnosis and follow-up treatment with a review of the diagnostic results of the International Workshop of Pediatric Oncology held in Rome, September 1986. Med Pediatr Oncol 1987, 15:181-187.
53. Felix CA, Reaman GH, Korsmeyer SJ, et al. Immunoglobulin and T cell receptor gene configuration in acute lymphoblastic leukemia of infancy. Blood 1987, 70:536-541.
54. Feusner J, Plaschkes J Hepatoblastoma and low birth weight: A trend or chance observation?. Med Pediatr Oncol 2002, 39:508-509.
55. Fong CT, Brodeur GM Down's syndrome and leukemia: Epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis. Cancer Genet Cytogenet 1987, 28:55-76.
56. Fong CT, Dracopoli NC, White PS, et al. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: Correlation with N- myc amplification. Proc Natl Acad Sci USA 1989, 86:3753-3757.
57. Ford AM, Bennett CA, Price CM, et al. Fetal origins of the TEL- AML1 fusion gene in identical twins with leukemia. Proc Natl Acad Sci U S A 1998, 95:4584-4588.
58. Ford AM, Ridge SA, Cabrera ME, et al. In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature 1993, 363:358-360.
59. Friis-Hansen B Body composition during growth: In vivo measurements and biochemical data correlated to differential anatomical growth. Pediatrics 1971, 47(Suppl 2):264.
60. Fuchs J, Rydzynski J, Von Schweinitz D, et al. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: A report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer 2002, 95:172-182.
61. Gadner H, Heitger A, Grois N, et al. Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group. Med Pediatr Oncol 1994, 23:72-80.
62. Gallo GE, Chemes HE The association of Wilms' tumor, male pseudohermaphroditism and diffuse glomerular disease (Drash syndrome): Report of eight cases with clinical and morphologic findings and review of the literature. Pediatr Pathol 1987, 7:175-189.
63. Gansler T, Chatten J, Varello M, et al. Flow cytometric DNA analysis of neuroblastoma: Correlation with histology and clinical outcome. Cancer 1986, 58:2453-2458.
64. Geatti O, Shapiro B, Sisson JC, et al. Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: Preliminary experience in ten cases. J Nucl Med 1985, 26:736-742.
65. Gill WB, Schumacher GF, Bibbo M Pathological semen and anatomical abnormalities of the genital tract in human male subjects exposed to diethylstilbestrol in utero. J Urol 1977, 117:477-480.
66. Gobel U, Calaminus G, Engert J, et al. Teratomas in infancy and childhood. Med Pediatr Oncol 1998, 31:8-15.
67. Gobel U, Schneider DT, Calaminus G, et al. Multimodal treatment of malignant sacrococcygeal germ cell tumors: A prospective analysis of 66 patients of the German cooperative protocols MAKEI 83/86 and 89. J Clin Oncol 2001, 19:1943-1950. Also available at http://www.jco.org/cgi/content/full/ 19/7/1943; http://www.jco.org/cgi/content/abstract/19/7/1943.
68. Gold EB, Sever LE Childhood cancers associated with parental occupational exposures. Occup Med 1994, 9:495-539.
69. Graf JL, Albanese CT, Jennings RW, et al. Successful fetal sacrococcygeal teratoma resection in a hydropic fetus. J Pediatr Surg 2000, 35:1489-1491.
70. Green DM, Breslow NE, Beckwith JB, et al. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 1998, 16:237-245.
71. Greenlund LJ, Letendre L, Tefferi A Acute leukemia during pregnancy: A single institutional experience with 17 cases. Leuk Lymphoma 2001, 41:571-577.
72. Gurney JG, Ross JA, Wall DA, et al. Infant cancer in the U.S.: Histology-specific incidence and trends, 1973 to 1992. J Pediatr Hematol Oncol 1997, 19:428-432.
73. Haas D, Ablin AR, Miller C, et al. Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment. Cancer 1988, 62:818-825.
74. Hamprecht K, Maschmann J, Vochem M, et al. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet 2001, 357:513-518.
75. Hann HW, Evans AE, Cohen IJ, et al. Biologic differences between neuroblastoma stages IV-S and IV. Measurement of serum ferritin and E-rosette inhibition in 30 children. N Engl J Med 1981, 305:425-429.
76. Hann HW, Evans AE, Siegel SE, et al. Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experience. Cancer Res 1985, 45:2843-2848.
77. Hatch EE, Herbst AL, Hoover RN, et al. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States). Cancer Causes Control 2001, 12:837-845.
78. Hayashi Y, Kanda N, Inaba T, et al. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer 1989, 63:126-132.
79. Haymond MW, Weldon VV Female pseudohermaphroditism secondary to a maternal virilizing tumor: Case report and review of the literature. J Pediatr 1973, 82:682-686.
80. Heerema NA, Arthur DC, Sather H, et al. Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: Impact of the 11q23 breakpoint on outcome: A report of the Children's Cancer Group. Blood 1994, 83:2274-2284.
81. Henter JI, Arico M, Egeler RM, et al. HLH-94: A treatment protocol for hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 1997, 28:342-347.
82. Herbst AL, Cole P, Colton T, et al. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol 1977, 128:43-50.
83. Herbst AL, Ulfelder H, Poskanzer DC Adenocarcinoma of the vagina: Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971, 284:878-881.
84. Holt SE, Brown EJ, Zipursky A Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome. J Pediatr Hematol Oncol 2002, 24:14-17.
85. Huddart SN, Muir KR, Parkes S, et al. Neuroblastoma: A 32-year population-based study implications for screening. Med Pediatr Oncol 1993, 21:96-102.
86. Ikeda Y, Masuzaki H, Nakayama D, et al. Successful management and perinatal outcome of pregnancy complicated with myelodysplastic syndrome. Leuk Res 2002, 26:255-260.
87. Isaacs HJ Tumors of the Fetus and Newborn 1997, W.B. Saunders Company, Philadelphia.
88. Ishii E, Ohga S, Tanimura M, et al. Clinical and epidemiologic studies of familial hemophagocytic lymphohistiocytosis in Japan. Japan LCH Study Group. Med Pediatr Oncol 1998, 30:276-283.
89. Jick H, Walker AM, Rothman KJ, et al. Vaginal spermicides and congenital disorders. JAMA 1981, 245:1329-1332.
90. Joshi VV, Banerjee AK, Yadav K, et al. Cystic partially differentiated nephroblastoma: A clinicopathologic entity in the spectrum of infantile renal neoplasia. Cancer 1977, 40:789-795.
91. Kaneko Y, Shikano T, Maseki N, et al. Clinical characteristics of infant acute leukemia with or without 11q23 translocations. Leukemia 1988, 2:672-676.
92. Katz F, Malcolm S, Gibbons B, et al. Cellular and molecular studies on infant null acute lymphoblastic leukemia. Blood 1988, 71:1438-1447.
93. Katzenstein HM, Kent PM, London WB, et al. Treatment and outcome of 83 children with intraspinal neuroblastoma: The Pediatric Oncology Group experience. J Clin Oncol 2001, 19:1047-1055.
94. Kinney H, Faix R, Brazy J The fetal alcohol syndrome and neuroblastoma. Pediatrics 1980, 66:130-132.
95. Kishkurno S, Ishida A, Takahashi Y, et al. A case of neonatal choriocarcinoma. Am J Perinatol 1997, 14:79-82.
96. Knezevich SR, Garnett MJ, Pysher TJ, et al. ETV6- NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res 1998, 58:5046-5048.
97. Knudson AG, Meadows AT, Nichols WW, et al. Chromosomal deletion and retinoblastoma. N Engl J Med 1976, 295:1120-1123.
98. Kubota T, Saitoh S, Matsumoto T, et al. Excess functional copy of allele at chromosomal region 11p15 may cause Wiedemann-Beckwith (EMG) syndrome. Am J Med Genet 1994, 49:378-383.
99. Kulkarni R, Wolf JS, Padiyar N, et al. Severe intrarenal fibrosis, infundibular stenosis, renal cysts, and persistent perilobar nephrogenic rests in a patient with Beckwith-Wiedemann syndrome 27 years after diffuse nephroblastomatosis and Wilms tumor: Natural progression or a consequence of treatment?. J Pediatr Hematol Oncol 2002, 24:389-393.
100. Kumar AP, Pratt CB, Coburn TP, et al. Treatment strategy for nodular renal blastema and nephroblastomatosis associated with Wilms' tumor. J Pediatr Surg 1978, 13:281-285.
101. Kurkchubasche AG, Halvorson EG, Forman EN, et al. The role of preoperative chemotherapy in the treatment of infantile fibrosarcoma. J Pediatr Surg 2000, 35:880-883.
102. Kynaston JA, Malcolm AJ, Craft AW, et al. Chemotherapy in the management of infantile fibrosarcoma. Med Pediatr Oncol 1993, 21:488-493.
103. Ladisch S, Gadner H Treatment of Langerhans cell histiocytosis evolution and current approaches. Br J Cancer Suppl 1994, 23:S41-S46.
104. Lange B The management of neoplastic disorders of haematopoiesis in children with Down's syndrome. Br J Haematol 2000, 110:512-524.
105. Lange BJ, Kobrinsky N, Barnard DR, et al. Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891. Blood 1998, 91:608-615.
106. Lergier JE, Jimenez E, Maldonado N, et al. Normal pregnancy in multiple myeloma treated with cyclophosphamide. Cancer 1974, 34:1018-1022.
107. Levitt GA, Stiller CA, Chessells JM Prognosis of Down's syndrome with acute leukaemia. Arch Dis Child 1990, 65:212-216.
108. Li FP Heritable fraction of unilateral Wilms tumor. Pediatrics 1988, 81:147.
109. Lobe TE, Wiener ES, Hays DM, et al. Neonatal rhabdomyosarcoma: The IRS experience. J Pediatr Surg 1994, 29:1167-1170.
110. Loeb DM, Hill DA, Dome JS Complete response of recurrent cellular congenital mesoblastic nephroma to chemotherapy. J Pediatr Hematol Oncol 2002, 24:478-481.
111. Loh ML, Ahn P, Perez-Atayde AR, et al. Treatment of infantile fibrosarcoma with chemotherapy and surgery: Results from the Dana-Farber Cancer Institute and Children's Hospital, Boston. J Pediatr Hematol Oncol 2002, 24:722-726.
112. Look AT, Hayes FA, Shuster JJ, et al. Clinical relevance of tumor cell ploidy and N- myc gene amplification in childhood neuroblastoma: A Pediatric Oncology Group study. J Clin Oncol 1991, 9:581-591.
113. Ludwig WD, Bartram CR, Harbott J, et al. Phenotypic and genotypic heterogeneity in infant acute leukemia. I. Acute lymphoblastic leukemia. Leukemia 1989, 3:431-439.
114. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990, 250:1233-1238.
115. Marina N, Fontanesi J, Kun L, et al. Treatment of childhood germ cell tumors: Review of the St. Jude experience from 1979 to 1988. Cancer 1992, 70:2568-2575.
116. Maris JM, Kyemba SM, Rebbeck TR, et al. Familial predisposition to neuroblastoma does not map to chromosome band 1p36. Cancer Res 1996, 56:3421-3425.
117. Maris JM, Matthay KK Molecular biology of neuroblastoma. J Clin Oncol 1999, 17:2264-2279. Also available at http://www.jco.org/cgi/content/full/17/7/2264 http://www.jco.org/cgi/content/abstract/17/7/2264.
118. Mathieu E, Merviel P, Antoine JM, et al. [Cancer and pregnancy: the obstetrician's standpoint]. Bull Cancer 2002, 89:758-764.
119. Matsumura M, Nishi T, Sasaki Y, et al. Prenatal diagnosis and treatment strategy for congenital mesoblastic nephroma. J Pediatr Surg 1993, 28:1607-1609.
120. Matthay KK, Sather HN, Seeger RC, et al. Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol 1989, 7:236-244.
121. Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13- cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999, 341:1165-1173.
122. Maurer HS, Pendergrass TW, Borges W, et al. The role of genetic factors in the etiology of Wilms' tumor: Two pairs of monozygous twins with congenital abnormalities (aniridia; hemihypertrophy) and discordance for Wilms' tumor. Cancer 1979, 43:205-208.
123. McLeod HL, Relling MV, Crom WR, et al. Disposition of antineoplastic agents in the very young child. Br J Cancer Suppl 1992, 18:S23-S29.
124. McNally OM, Tran M, Fortune D, et al. Successful treatment of mother and baby with metastatic choriocarcinoma. Int J Gynecol Cancer 2002, 12:394-398.
125. Meadows AT, Lichtenfeld JL, Koop CE Wilms's tumor in three children of a woman with congenital hemihypertrophy. N Engl J Med 1974, 291:23-24.
126. Melnick S, Cole P, Anderson D, et al. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: An update. N Engl J Med 1987, 316:514-516.
127. Monson RR Prenatal X-Ray exposure and cancer in children. Radiation Carcinogenesis: Epidemiology and Biological Significance 1997, Raven Press, New York. J.D. Boice, J.F. Fraumeni (Eds.).
128. Mora J, Dobrenis AM, Bussel JB, et al. Spontaneous remission of congenital acute nonlymphoblastic leukemia with normal karyotype in twins. Med Pediatr Oncol 2000, 35:110-113.
129. Morgan E, Baum E, Breslow N, et al. Chemotherapy-related toxicity in infants treated according to the Second National Wilms' Tumor Study. J Clin Oncol 1988, 6:51-55.
130. Moss TJ, Seeger RC, Kindler-Rohrborn A Immunohistologic detection and phenotyping of neuroblastoma cells in bone marrow using cytoplasmic neuron-specific enolase and cell surface antigens. Advances in Neuroblastoma Research 1985, Alan R. Liss, New York. A. Evans, G. D'Angio, R.C. Seeger (Eds.).
131. Mundschau G, Gurbuxani S, Gamis AS, et al. Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis. Blood 2003, 101:4298-4300.
132. Nair R, Pai SK, Saikia TK, et al. Malignant germ cell tumors in childhood. J Surg Oncol 1994, 56:186-190.
133. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, et al. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 1993, 328:847-854.
134. Nakagawara A, Zaizen Y, Ikeda K, et al. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas. Cancer 1991, 68:2037-2044.
135. Newsham I, Kindler-Rohrborn A, Daub D, et al. A constitutional BWS-related t(11;16) chromosome translocation occurring in the same region of chromosome 16 implicated in Wilms' tumors. Genes Chromosomes Cancer 1995, 12:1-7.
136. Nickerson HJ, Matthay KK, Seeger RC, et al. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: A Children's Cancer Group study. J Clin Oncol 2000, 18:477-486. Also available at http://www.jco.org/cgi/content/full/18/3/477 http://www.jco.org/cgi/content/abstract/18/3/477.
137. Ninane J, Rombouts JJ, Cornu G Chemotherapy for infantile fibrosarcoma [letter; comments] [see comments]. Med Pediatr Oncol 1991, 19:209.
138. Odom LF, Gordon EM Acute monoblastic leukemia in infancy and early childhood: successful treatment with an epipodophyllotoxin. Blood 1984, 64:875-882.
139. Olshan AF, De Roos AJ, Teschke K, et al. Neuroblastoma and parental occupation. Cancer Causes Control 1999, 10:539-549.
140. Olshan AF, Smith J, Cook MN, et al. Hormone and fertility drug use and the risk of neuroblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. Am J Epidemiol 1999, 150:930-938.
141. Packer RJ, Biegel JA, Blaney S, et al. Atypical teratoid/rhabdoid tumor of the central nervous system: Report on workshop. J Pediatr Hematol Oncol 2002, 24:337-342.
142. Pastore G, Carli M, Lemerle J, et al. Epidemiological features of Wilms' tumor: Results of studies by the International Society of Paediatric Oncology (SIOP). Med Pediatr Oncol 1988, 16:7-11.
143. Pautier P, Lhomme C, Morice P [Cancer and pregnancy: The medical oncologist's point of view]. Bull Cancer 2002, 89:779-785.
144. Pavlidis NA Coexistence of pregnancy and malignancy. Oncologist 2002, 7:279-287.
145. Pelkonen O, Kaltiala EH, Larmi TK, et al. Comparison of activities of drug-metabolizing enzymes in human fetal and adult livers. Clin Pharmacol Ther 1973, 14:840-846.
146. Perez CA, Matthay KK, Atkinson JB, et al. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: A children's cancer group study. J Clin Oncol 2000, 18:18-26. Also available at http://www.jco.org/cgi/content/full/18/1/18 http://www.jco.org/cgi/content/ abstract/18/1/18.
147. Pettinato G, Manivel JC, Wick MR, et al. Classical and cellular (atypical) congenital mesoblastic nephroma: A clinicopathologic, ultrastructural, immunohistochemical, and flow cytometric study. Hum Pathol 1989, 20:682-690.
148. Phillips M, Dicks-Mireaux C, Kingston J, et al. Hepatoblastoma and polyposis coli (familial adenomatous polyposis). Med Pediatr Oncol 1989, 17:441-447.
149. Pilling GP Wilms' tumor in seven children with congenital aniridia. J Pediatr Surg 1975, 10:87-96.
150. Pui CH, Behm FG, Crist WM Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 1993, 82:343-362.
151. Pui CH, Evans WE Acute lymphoblastic leukemia in infants. J Clin Oncol 1999, 17:438-440.
152. Pui CH, Gaynon PS, Boyett JM, et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 2002, 359:1909-1915.
153. Pui CH, Kane JR, Crist WM Biology and treatment of infant leukemias. Leukemia 1995, 9:762-769.
154. Pui CH, Raimondi SC, Murphy SB, et al. An analysis of leukemic cell chromosomal features in infants. Blood 1987, 69:1289-1293.
155. Pui CH, Raimondi SC, Srivastava DK, et al. Prognostic factors in infants with acute myeloid leukemia. Leukemia 2000, 14:684-687.
156. Pui CH Childhood leukemias. N Engl J Med 1995, 332:1618-1630.
157. Raney RB, Chatten J, Littman P, et al. Treatment strategies for infants with malignant sacrococcygeal teratoma. J Pediatr Surg 1981, 16:573-577.
158. Reaman G, Zeltzer P, Bleyer WA, et al. Acute lymphoblastic leukemia in infants less than one year of age: A cumulative experience of the Children's Cancer Study Group. J Clin Oncol 1985, 3:1513-1521.
159. Riccardi VM, Sujansky E, Smith AC, et al. Chromosomal imbalance in the aniridia-Wilms' tumor association: 11p interstitial deletion. Pediatrics 1978, 61:604-610.
160. Ridgway D, Benda GI, Magenis E, et al. Transient myeloproliferative disorder of the Down type in the normal newborn. Am J Dis Child 1990, 144:1117-1119.
161. Ries LAG, Smith MA, Gurney JG, et al. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995 1999, Cancer Statistics Branch, National Cancer Institute, Bethesda, Md.
162. Roberts CW, Galusha SA, McMenamin ME, et al. Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. Proc Natl Acad Sci USA 2000, 97:13796-13800.
163. Rosner F, Lee SL Down's syndrome and acute leukemia: Myeloblastic or lymphoblastic? Report of forty-three cases and review of the literature. Am J Med 1972, 53:203-218.
164. Ross JA, Gurney JG Hepatoblastoma incidence in the United States from 1973 to 1992. Med Pediatr Oncol 1998, 30:141-142.
165. Ross JA, Potter JD, Reaman GH, et al. Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): A report from the Children's Cancer Group. Cancer Causes Control 1996, 7:581-590.
166. Ross JA Dietary flavonoids and the MLL gene: A pathway to infant leukemia?. Proc Natl Acad Sci U S A 2000, 97:4411-4413.
167. Rouzan IA An analysis of research and clinical practice in neonatal pain management. J Am Acad Nurse Pract 2001, 13:57-60.
168. Rubin BP, Chen CJ, Morgan TW, et al. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: Cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol 1998, 153:1451-1458.
169. Rubnitz JE, Link MP, Shuster JJ, et al. Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: A Pediatric Oncology Group study. Blood 1994, 84:570-573.
170. Rudnick E, Khakoo Y, Antunes NL, et al. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: Clinical outcome and antineuronal antibodies a report from the Children's Cancer Group Study. Med Pediatr Oncol 2001, 36:612-622.
171. Safdar A, Johnson N, Gonzalez F, et al. Adult T-cell leukemia-lymphoma during pregnancy. N Engl J Med 2002, 346:2014-2015.
172. Sande JE, Arceci RJ, Lampkin BC Congenital and neonatal leukemia. Semin Perinatol 1999, 23:274-285.
173. Schilling FH, Spix C, Berthold F, et al. Neuroblastoma screening at one year of age. N Engl J Med 2002, 346:1047-1053. Also available at http://content.nejm.org/cgi/content/full/346/14/1047 http://content.nejm.org/cgi/content/abstract/346/14/1047.
174. Schmidt ML, Lukens JN, Seeger RC, et al. Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study. J Clin Oncol 2000, 18:1260-1268. Also available at http://www.jco.org/cgi/content/full/18/6/1260 http://www.jco.org/cgi/content/abstract/18/6/1260.
175. Schofield DE, Yunis EJ, Fletcher JA Chromosome aberrations in mesoblastic nephroma. Am J Pathol 1993, 143:714-724.
176. Schouten-Van Meeteren AY, Moll AC, Imhof SM, Veerman AJ Overview: Chemotherapy for retinoblastoma: An expanding area of clinical research. Med Pediatr Oncol 2002, 38:428-438.
177. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N- myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985, 313:1111-1116.
178. Seibel NL, Sommer A, Miser J Transient neonatal leukemoid reactions in mosaic trisomy 21. J Pediatr 1984, 104:251-254.
179. Severson RK, Buckley JD, Woods WG, et al. Cigarette smoking and alcohol consumption by parents of children with acute myeloid leukemia: An analysis within morphological subgroups a report from the Children's Cancer Group. Cancer Epidemiol Biomarkers Prev 1993, 2:433-439.
180. Sheng WQ, Hisaoka M, Okamoto S, et al. Congenital-infantile fibrosarcoma. A clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcripts using paraffin-embedded tissues. Am J Clin Pathol 2001, 115:348-355.
181. Shimada H, Ambros IM, Dehner LP, et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 1999, 86:364-372.
182. Shimada H, Ambros IM, Dehner LP, et al. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer 1999, 86:349-363.
183. Shu XO, Ross JA, Pendergrass TW, et al. Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: A Childrens Cancer Group study. J Natl Cancer Inst 1996, 88:24-31.
184. Silverman LB, McLean TW, Gelber RD, et al. Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium. Cancer 1997, 80:2285-2295.
185. Singh VP, Kannan N, Rajagopal G, et al. Congenital fibrosarcoma. Report of three cases. Indian J Cancer 1995, 32:179-182.
186. Sitarz AL, Santulli TV, Wigger HJ, et al. Complete maturation of neuroblastoma with bone metastases in documented stages. J Pediatr Surg 1975, 10:533-536.
187. Sotelo-Avila C, Gonzalez-Crussi F, Fowler JW Complete and incomplete forms of Beckwith-Wiedemann syndrome: Their oncogenic potential. J Pediatr 1980, 96:47-50.
188. Sotelo-Avila C, Gonzalez-Crussi F, Starling KA Wilms' tumor in a patient with an incomplete form of Beckwith-Wiedemann syndrome. Pediatrics 1980, 66:121-123.
189. Stewart AM, Draper GJ X-rays and childhood cancer. Lancet 1968, 2:828-829.
190. Stewart CF, Hampton EM Effect of maturation on drug disposition in pediatric patients. Clin Pharm 1987, 6:548-564.
191. Strick R, Strissel PL, Borgers S, et al. Dietary bioflavonoids induce
192. Strohsnitter WC, Noller KL, Hoover RN, et al. Cancer risk in men exposed in utero to diethylstilbestrol. J Natl Cancer Inst 2001, 93:545-551. Also available at http://jnci.oupjournals.org/cgi/content/full/93/7/545 http://jnci.oupjournals.org/cgi/content/abstract/93/7/545.
193. Suda J, Eguchi M, Akiyama Y, et al. Differentiation of blast cells from a Down's syndrome patient with transient myeloproliferative disorder. Blood 1987, 69:508-512.
194. Suita S, Zaizen Y, Sera Y, et al. Mass screening for neuroblastoma: Quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan. J Pediatr Surg 1996, 31:555-558.
195. Suzuki T, Bogenmann E, Shimada H, et al. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J Natl Cancer Inst 1993, 85:377-384.
196. Swift PG, Bloom SR, Harris F Watery diarrhoea and ganglioneuroma with secretion of vasoactive intestinal peptide. Arch Dis Child 1975, 50:896-899.
197. Takeuchi LA, Hachitanda Y, Woods WG, et al. Screening for neuroblastoma in North America: Preliminary results of a pathology review from the Quebec Project. Cancer 1995, 76:2363-2371.
198. Taub JW, Matherly LH, Stout ML, et al. Enhanced metabolism of 1-beta-D-arabinofuranosylcytosine in Down syndrome cells: A contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia. Blood 1996, 87:3395-3403.
199. Taub JW, Stout ML, Buck SA, et al. Myeloblasts from Down syndrome children with acute myeloid leukemia have increased in vitro sensitivity to cytosine arabinoside and daunorubicin. Leukemia 1997, 11:1594-1595.
200. Taylor WF, Myers M, Taylor WR Extrarenal Wilms' tumour in an infant exposed to intrauterine phenytoin. Lancet 1980, 2:481-482.
201. Titgemeyer C, Grois N, Minkov M, et al. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study. Med Pediatr Oncol 2001, 37:108-114.
202. Tolar J, Coad JE, Neglia JP Transplacental transfer of small-cell carcinoma of the lung. N Engl J Med 2002, 346:1501-1502.
203. Valteau-Couanet D, Benhamou E, Vassal G, et al. Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma. Bone Marrow Transplant 2000, 25:937-942.
204. van Wering ER, Kamps WA Acute leukemia in infants: A unique pattern of acute nonlymphocytic leukemia. Am J Pediatr Hematol Oncol 1986, 8:220-224.
205. Versteege I, Sevenet N, Lange J, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 1998, 394:203-206.
206. Voelkerding KV, Sandhaus LM, Belov L, et al. Clonal B-cell proliferation in an infant with congenital HIV infection and immune thrombocytopenia. Am J Clin Pathol 1988, 90:470-474.
207. Voute PA, Wadman SK, van Putten WJ Congenital neuroblastoma: Symptoms in the mother during pregnancy. Clin Pediatr (Phila) 1970, 9:206-207.
208. Wai DH, Knezevich SR, Lucas T, et al. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells. Oncogene 2000, 19:906-915.
209. Ward RM, Bristow RE Cancer and pregnancy: Recent developments. Curr Opin Obstet Gynecol 2002, 14:613-617.
210. Wechsler J, Greene M, McDevitt MA Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet 2002, 32:148-152.
211. Weeks DA, Beckwith JB, Mierau GW, et al. Rhabdoid tumor of kidney: A report of 111 cases from the National Wilms' Tumor Study Pathology Center. Am J Surg Pathol 1989, 13:439-458.
212. Wiggs J, Nordenskjold M, Yandell D, et al. Prediction of the risk of hereditary retinoblastoma, using DNA polymorphisms within the retinoblastoma gene. N Engl J Med 1988, 318:151-157.
213. Wilmore HP, White GF, Howell RT, et al. Germline and somatic abnormalities of chromosome 7 in Wilms' tumor. Cancer Genet Cytogenet 1994, 77:93-98.
214. Woods WG, Gao RN, Shuster JJ, et al. Screening of infants and mortality due to neuroblastoma. N Engl J Med 2002, 346:1041-1046. Also available at http://content.nejm.org/cgi/content/full/346/14/1041 http://content.nejm.org/cgi/content/abstract/346/14/1041.
215. Woods WG, Tuchman M, Robison LL, et al. A population-based study of the usefulness of screening for neuroblastoma. Lancet 1996, 348:1682-1687.
216. Woods WG, Tuchman M Neuroblastoma: The case for screening infants in North America. Pediatrics 1987, 79:869-873.
217. Yamamoto K, Hanada R, Kikuchi A, et al. Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol 1998, 16:1265-1269.
218. Yamamoto K, Hayashi Y, Hanada R, et al. Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan. J Clin Oncol 1995, 13:2033-2038.
219. Yoshimoto Y, Kato H, Schull WJ A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors: Cancer risk among in utero-exposed survivors. J Radiat Res (Tokyo) 1991, 32:231-238.
220. Yunis JJ, Ramsay NK Familial occurrence of the aniridia-Wilms tumor syndrome with deletion 11p13-14.1. J Pediatr 1980, 96:1027-1030.
221. Ziemin-van der Poel S, McCabe NR, Gill HJ, et al. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci U S A 1991, 88:10735-10739.